Practice Areas Capital Markets - Equity Capital
Share This

Capital Markets - Equity Capital

The ByrneWallace Equity Capital Markets team is one of the most highly regarded in Ireland. With excellent long-standing relationships with local finance houses, investments banks and listed companies, we offer our clients comprehensive and commercially driven solutions to address the full range of capital financing issues. 

Our team has a wealth of experience advising listed companies, sponsors/nominated advisers, placing agents, investors and other stakeholders on the full spectrum of capital markets transactions and public takeovers, as well as general compliance issues and continuing obligations under stock exchange rules and the Irish Takeover Rules. 

Our team also has particular experience advising boards of public companies in high profile cases in contentious scenarios including disputes with major shareholders centred on the removal of executive board members. 

We operate cross-functional teams to ensure a comprehensive approach to all aspects of the transaction. We negotiate robustly on your behalf to ensure that the deal is structured to your benefit. To this end, team includes experienced lawyers from our banking, financial services, corporate, technology, intellectual property, regulatory and tax teams.

Our services

We advise domestic and international clients on a broad range of equity capital market transactions, including:

  • IPOs
  • Secondary fundraisings, rights issues and open offers
  • Corporate governance and shareholder disputes
  • Pre-IPO fundraisings and reorganisations
  • Privatisations
  • Continuing obligations under stock exchange rules, market abuse and securities law issues
  • Irish Takeovers Rules

For advice on matters relating to equity capital markets, contact Gerry Beausang, Partner, Corporate. 


KEY CONTACT
Gerry Beausang gbeausang@byrnewallace.com +353 1 691 5866 +353 1 691 5010
THE TEAM      
Feargal Brennan fbrennan@byrnewallace.com +353 1 691 5276 +353 1 691 5010
RELATED TESTIMONIALS
Gerry Beausang, who heads the team at ByrneWallace, acted for Aminex on its £20m placing and open offer. Colin S... Legal 500 2017 - Capital Markets view all related testimonials
ByrneWallace has worked on equity capital markets transactions for pharmaceuticals and software companies, notabl... Legal 500 2016 - Capital Markets view all related testimonials
Feargal Brennan heads ByrneWallace’s team, which has recently undertaken work for Cosmo Pharmaceuticals and Sof... Legal 500 2015 - Capital Markets view all related testimonials
ByrneWallace acted for the Irish subsidiary of Amarin Corporation on its $100m hybrid debt-like financing with Bi... Legal 500 2014 - Capital Markets view all related testimonials
ByrneWallace displays ‘excellent attention to detail’ and [the firm] is ‘capable of coming up with solution... Legal 500 2010 - Capital Markets view all related testimonials
[The Firm] is highly recommended and "responds quickly, provides top advice and is attentive to detail"...[The Fi... Chambers Global 2010 - Capital Markets view all related testimonials
RECENT WORK
  • Aminex plc

    Advising Aminex plc on a proposed equity funding to raise up to Stg£19.5m (US$25.4m) by the issue of new shares

  • Aminex plc

    ByrneWallace advised dual listed oil and gas exploration and production company Aminex plc in relation to a €2.3m placing of new shares.

  • Nexvet Biopharma plc

    Acted for Nexvet Biopharma plc in relation to its fully underwritten US$40m IPO

view all related recent work